Clover Health Q1 revenue jumps 62%

Clover Health Investments

06/05/2026 21:54

Overview

US physician enablement tech firm's Q1 revenue grew 62% yr/yr, beating analyst expectations

Q1 adjusted EBITDA rose 56% yr/yr, beating analyst expectations

Company delivered positive GAAP net income and expects full-year profitability

Outlook

Clover Health sees 2026 revenue between $2.81 bln and $2.92 bln

Company expects 2026 GAAP net income of $0 mln to $20 mln

Clover Health expects to achieve first full-year GAAP net income profitability in 2026

Result Drivers

MEMBERSHIP GROWTH - Market-leading Medicare Advantage membership growth drove revenue and profit gains

TECHNOLOGY PLATFORM - Deeper clinical engagement and earlier intervention supported by Clover Assistant contributed to improved outcomes and financial performance, per CEO Andrew Toy

COST TRENDS - Medical cost trends developed in line with expectations, according to interim CFO Clay Thornton

Company press release: ID:nGNX6DshSm

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$749 mln
$714.89 mln (3 Analysts)
Q1 Net Income
$27 mln
Q1 Adjusted EBITDA
Beat
$40 mln
$35.28 mln (3 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the managed healthcare peer group is "buy."

Wall Street's median 12-month price target for Clover Health Investments Corp is $2.63, about 0.6% above its May 5 closing price of $2.61

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)